Table 7. BSID-II by MA exposure.
Standard scores | Mean ± (SD) | Unadjusted P-Value | aAdjusted P-Value | |
---|---|---|---|---|
Exposed | Comparison | |||
12 months | (N = 162) | (N= 169) | ||
MDI | 94.23 ± 9.56 | 94.28 ± 10.64 | 0.964 | 0.785 |
PDI | 93.86 ± 11.32 | 93.24 ± 12.60 | 0.638 | 0.964 |
24 months | (N = 147) | (N= 139) | ||
MDIb | 84.51 ± 12.03 | 83.53 ± 13.36 | 0.515 | 0.216 |
(N = 147) | (N= 137) | |||
PDIc | 94.71 ± 13.32 | 93.45 ± 12.38 | 0.412 | 0.549 |
36 months | (N = 135) | (N= 141) | ||
MDIb | 88.90 ±11.11 | 87.76 ± 15.27 | 0.481 | 0.240 |
(N = 133) | (N= 140) | |||
PDIc | 92.79 ± 11.06 | 92.43 ±11.23 | 0.789 | 0.230 |
Adjusted for study site, birth weight, gender, prenatal drug exposures, and socioeconomic status.
MDI: 2 cases with missing values at 24 months; 2 cases with missing values at 36 months.
PDI: 4 cases with missing values at 24 months; 5 cases with missing values at 36 months.